These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29134378)

  • 1. Organ Preservation in Rectal Cancer After Chemoradiation: Should We Extend the Observation Period in Patients with a Clinical Near-Complete Response?
    Hupkens BJP; Maas M; Martens MH; van der Sande ME; Lambregts DMJ; Breukink SO; Melenhorst J; Houwers JB; Hoff C; Sosef MN; Leijtens JWA; Berbee M; Beets-Tan RGH; Beets GL
    Ann Surg Oncol; 2018 Jan; 25(1):197-203. PubMed ID: 29134378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Long-term outcome of patients with rectal cancer who achieve complete or near complete clinical responses after neoadjuvant therapy: a multicenter registry study of data from the Chinese Watch and Wait Database].
    Zhao YM; Wang WH; Zhang W; Wang L; Li S; Wang JW; Liao LE; Yu GY; Sun Z; Qu YL; Gong Y; Lu Y; Wu T; Li YF; Wang Q; Zhao GH; Xiao Y; Ding PR; Zhang Z; Wu AW
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):372-382. PubMed ID: 38644243
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparing outcomes and cost in surgery versus watch & wait surveillance of patients with rectal cancer post neoadjuvant long course chemoradiotherapy.
    Crean R; Glyn T; McCombie A; Frizelle F
    ANZ J Surg; 2024 Jun; 94(6):1151-1160. PubMed ID: 38486505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "WATCH AND WAIT" STRATEGY IN RECTAL CANCER PATIENTS WITH A COMPLETE CLINICAL RESPONSE AFTER NEOADJUVANT CHEMORADIATION THERAPY: A SINGLE-CENTER EXPERIENCE.
    Kokaine L; Radzina M; Liepa M; Gerina-Berzina A; Sīviņa E; Nikolajeva J; Gardovskis A; Gardovskis J; Miklaševičs E
    Exp Oncol; 2024 May; 46(1):53-60. PubMed ID: 38852052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Operative trends following the adoption of nonoperative management of rectal cancer.
    Brewer J; Kamara M; Huebner M; Taxakis E; Grajewski K; Ramm C; Cleary RK
    J Surg Oncol; 2024 May; 129(6):1139-1149. PubMed ID: 38406980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whether the watch-and-wait strategy has application value for rectal cancer with clinical complete response after neoadjuvant chemoradiotherapy? A network meta-analysis.
    Du R; Chang Y; Zhang J; Cheng Y; Li Y; Zhang C; Zhang J; Xu L; Liu Y
    Asian J Surg; 2024 Feb; 47(2):853-863. PubMed ID: 38042663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Watch & wait - Post neoadjuvant imaging for rectal cancer.
    El Homsi M; Bercz A; Chahwan S; Fernandes MC; Javed-Tayyab S; Golia Pernicka JS; Nincevic J; Paroder V; Ruby L; Smith JJ; Petkovska I
    Clin Imaging; 2024 Jun; 110():110166. PubMed ID: 38669916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-operative management in low-lying rectal cancers undergoing chemoradiation.
    Datta D; Engineer R; Saklani A; D'souza A; Baheti A; Kumar S; Krishnatry R; Ostwal V; Ramaswamy A; Patil P
    J Cancer Res Ther; 2024 Jan; 20(1):417-422. PubMed ID: 38554355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A primer on rectal MRI in patients on watch-and-wait treatment for rectal cancer.
    Gollub MJ; Costello JR; Ernst RD; Lee S; Maheshwari E; Petkovska I; Wasnik AP; Horvat N
    Abdom Radiol (NY); 2023 Sep; 48(9):2836-2873. PubMed ID: 37099182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Watch and Wait in Rectal Cancer Patients with Residual Mucin on MRI following Neoadjuvant Therapy.
    Judge SJ; Malekzadeh P; Corines MJ; Gollub MJ; Horvat N; Gonen M; Saltz L; Cercek A; Romesser P; Crane C; Shia J; Wei I; Widmar M; Pappou E; Nash GM; Smith JJ; Paty PB; Garcia-Aguilar J; Weiser MR
    J Natl Cancer Inst; 2024 Jun; ():. PubMed ID: 38937278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Norwegian Watch and Wait study: Norwait for rectal cancer. A report from a failed study-a word of caution.
    Wasmuth HH; Færden AE
    Updates Surg; 2024 Jul; ():. PubMed ID: 39003668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Organ preservation and watch-and-wait strategy in esophageal cancer: a promising future].
    Jiao H; Tan LJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Apr; 27(4):348-352. PubMed ID: 38644239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ preservation in rectal cancer: a synopsis of current guidelines.
    Borstlap WAA; van Oostendorp SE; Klaver CEL; Hahnloser D; Cunningham C; Rullier E; Bemelman WA; Tuynman JB; Tanis PJ;
    Colorectal Dis; 2017 Nov; ():. PubMed ID: 29136328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Red and processed meat consumption and colorectal cancer risk: a systematic review and meta-analysis.
    Zhao Z; Feng Q; Yin Z; Shuang J; Bai B; Yu P; Guo M; Zhao Q
    Oncotarget; 2017 Oct; 8(47):83306-83314. PubMed ID: 29137344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is neoadjuvant chemoradiation with dose-escalation and consolidation chemotherapy sufficient to increase surgery-free and distant metastases-free survival in baseline cT3 rectal cancer?
    São Julião GP; Habr-Gama A; Vailati BB; Aguilar PB; Sabbaga J; Araújo SEA; Mattacheo A; Alexandre FA; Fernandez LM; Gomes DB; Gama-Rodrigues J; Perez RO
    Eur J Surg Oncol; 2018 Jan; 44(1):93-99. PubMed ID: 29217398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organ-Preserving Strategies for the Management of Near-Complete Responses in Rectal Cancer after Neoadjuvant Chemoradiation.
    Lynn PB; Strombom P; Garcia-Aguilar J
    Clin Colon Rectal Surg; 2017 Nov; 30(5):395-403. PubMed ID: 29184476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of the Complete Clinical Response.
    Habr-Gama A; São Julião GP; Vailati BB; Castro I; Raffaele D
    Clin Colon Rectal Surg; 2017 Nov; 30(5):387-394. PubMed ID: 29184475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.
    Cercek A; Roxburgh CSD; Strombom P; Smith JJ; Temple LKF; Nash GM; Guillem JG; Paty PB; Yaeger R; Stadler ZK; Seier K; Gonen M; Segal NH; Reidy DL; Varghese A; Shia J; Vakiani E; Wu AJ; Crane CH; Gollub MJ; Garcia-Aguilar J; Saltz LB; Weiser MR
    JAMA Oncol; 2018 Jun; 4(6):e180071. PubMed ID: 29566109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase 2 Neoadjuvant Treatment Intensification Trials in Rectal Cancer: A Systematic Review.
    Teo MTW; McParland L; Appelt AL; Sebag-Montefiore D
    Int J Radiat Oncol Biol Phys; 2018 Jan; 100(1):146-158. PubMed ID: 29254769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-inferiority multicenter prospective randomized controlled study of rectal cancer T
    Serra-Aracil X; Pericay C; Golda T; Mora L; Targarona E; Delgado S; Reina A; Vallribera F; Enriquez-Navascues JM; Serra-Pla S; Garcia-Pacheco JC;
    Int J Colorectal Dis; 2018 Feb; 33(2):241-249. PubMed ID: 29234923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.